Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03141619 : Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion

1. Adults ? 18 years old

2. Admitted to a critical care unit requiring one or more of the following:

(a) Respiratory failure requiring invasive mechanical ventilation with an expected
duration >24 hours (b) Shock of any etiology. Shock is defined by the need for one of
the following vasopressors/inotropes: (i) Dopamine ?7.5 mcg/kg/min (ii) Dobutamine ?5
mcg/kg/min (iii) Norepinephrine ?5 mcg/min (iv) Phenylephrine ?75 mcg/min (v)
Epinephrine at any dose (vi) Milrinone at any dose (if used in conjunction with
another agent) (vii) Vasopressin ?0.03 u/min(if used in conjunction with another
agent)

Exclusion:

1. Admission to the ICU > 24 hours

2. Life expectancy <24 hours

3. Admitting diagnosis that affects the central nervous system

4. Any reason that the subject may not be able to participate in the follow up
assessments (i.e. limb amputation, paresis, neuromuscular disorders)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03141619      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740